FFT analysis of isoflurane levels, suppression duration comparison across conditions, and sample oscillations at different isoflurane levels. by Mohammad-Mahdi Abolghasemi (22367296)

Estimated average absolute and relative changes in energy (kcal/capita/day) from the no-policy counterfactual by phase, high-in status, and SES. by Lindsey Smith Taillie (3159258)

Subjects:

Estimated average absolute and relative changes in energy (kcal/capita/day) from the no-policy counterfactual by phase and number of excess nutrients of concern. by Lindsey Smith Taillie (3159258)

Subjects:

Weighted sociodemographic characteristics of the Kantar WorldPanel sample by year. by Lindsey Smith Taillie (3159258)

Subjects:

Estimated average absolute and relative changes from the no-policy counterfactual by phase and high-in status. by Lindsey Smith Taillie (3159258)

Subjects:

Mean observed, fitted, and counterfactual energy, saturated fat, sodium, and sugar per capita per day from high-in food and beverage purchases. by Lindsey Smith Taillie (3159258)

Subjects:

Estimated average absolute and relative changes from the no-policy counterfactual by phase and beverage group. by Lindsey Smith Taillie (3159258)

Subjects:

Mean observed, fitted, and counterfactual energy, saturated fat, sodium, and sugar per capita per day from total food and beverage purchases. by Lindsey Smith Taillie (3159258)

Subjects:

Estimated average absolute and relative changes from the no-policy counterfactual by phase and food group. by Lindsey Smith Taillie (3159258)

Subjects:

IGF-1 increases mature collagen in females in mice with systemic MMP8 deficiency and myeloid MMP8 reintroduction. by Patricia Snarski (22305205)

“…(n = 5−12 mice per group). Green fibers are significantly decreased (p = 0.0268) in IGF-1 treated mice that have MMP8 only in MF. …”

Representative liver histology of normal control (A), low-dose Olanzapine (B), negative control (C), test (D), and positive control (E) groups (Hematoxylin and Eosin stain, ×400 ma... by Elsie D. Oduor (22521785)

Subjects:

Ingenuity pathway analysis. by Wendy J. Bailey (14926392)

Subjects:

Regional differences in percentage changes of N07BA drug prescribing rates during the pandemic. by Dainty Ei (22265317)

Subjects:

Hypnotic and sedative (N05C) prescribing changes from 2014 to 2022. by Dainty Ei (22265317)

Subjects:

Regional differences in percentage changes of N05B prescribing rates during the pandemic. by Dainty Ei (22265317)

Subjects:

Drugs used in alcohol dependence (N07BB) prescribing changes from 2014 to 2022 (females). by Dainty Ei (22265317)

Subjects:

Regional differences in percentage changes of N05C prescribing rates during the pandemic. by Dainty Ei (22265317)

Subjects:

Regional differences in percentage changes of N06A prescribing rates during the pandemic. by Dainty Ei (22265317)

Subjects:

Drugs used in addictive disorders (N07B) prescribing changes from 2014 to 2022. by Dainty Ei (22265317)

Subjects:

Anxiolytic (N05B) prescribing changes from 2014 to 2022. by Dainty Ei (22265317)

Subjects: